Literature DB >> 10527879

Residues within the HFRIGC sequence of HIV-1 vpr involved in growth arrest activities.

J M Berglez1, L A Castelli, S A Sankovich, S C Smith, C C Curtain, I G Macreadie.   

Abstract

HIV-1 Vpr is a virion-associated protein that can cause growth arrest when produced inside the cell but when added externally it can cause cell death. Employing the yeast model system, the C-terminal domain, in particular the sequence HFRIGCRHSRIG (Vpr(71-82)), is essential for both the growth arrest and cytocidal activities. Conservation of this sequence in HIV-2 and SIV suggests that these residues may be functionally important. Using site-directed mutagenesis we show that the most highly conserved aa residues, His71 and Gly75, were important for the cell cycle inhibitory effects. In contrast, we show that the wild-type Vpr(71-82) peptide and three variants of this peptide with Gly75 changed to Ser, Ala, and Ile all exhibited the same cytocidal activity suggesting that the intracellular and extracellular effects are unrelated. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527879     DOI: 10.1006/bbrc.1999.1511

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  The first HxRxG motif in simian immunodeficiency virus mac239 Vpr is crucial for G(2)/M cell cycle arrest.

Authors:  Sandra M Mueller; Sabine M Lang
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Human immunodeficiency virus type 1 Vpr induces G2 checkpoint activation by interacting with the splicing factor SAP145.

Authors:  Yasuhiko Terada; Yuko Yasuda
Journal:  Mol Cell Biol       Date:  2006-08-21       Impact factor: 4.272

3.  Activation of the ATR pathway by human immunodeficiency virus type 1 Vpr involves its direct binding to chromatin in vivo.

Authors:  Maoyi Lai; Erik S Zimmerman; Vicente Planelles; Junjie Chen
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Phosphorylation of human immunodeficiency virus type 1 Vpr regulates cell cycle arrest.

Authors:  Y Zhou; L Ratner
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

5.  The host-pathogen interaction of human cyclophilin A and HIV-1 Vpr requires specific N-terminal and novel C-terminal domains.

Authors:  Sara M Ø Solbak; Victor Wray; Ole Horvli; Arnt J Raae; Marte I Flydal; Petra Henklein; Peter Henklein; Manfred Nimtz; Ulrich Schubert; Torgils Fossen
Journal:  BMC Struct Biol       Date:  2011-12-20

6.  The HIV-derived protein Vpr52-96 has anti-glioma activity in vitro and in vivo.

Authors:  Jens Kübler; Stefanie Kirschner; Linda Hartmann; Grit Welzel; Maren Engelhardt; Carsten Herskind; Marlon R Veldwijk; Christian Schultz; Manuela Felix; Gerhard Glatting; Patrick Maier; Frederik Wenz; Marc A Brockmann; Frank A Giordano
Journal:  Oncotarget       Date:  2016-07-19

7.  Analysis of HIV-1 Vpr determinants responsible for cell growth arrest in Saccharomyces cerevisiae.

Authors:  Xiao-Jian Yao; Nicole Rougeau; Ghislaine Duisit; Julie Lemay; Eric A Cohen
Journal:  Retrovirology       Date:  2004-08-16       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.